Beta Bionics, Inc. BBNX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.06% | -6.89% | -62.59% | 5.23% | 15.77% |
| Total Depreciation and Amortization | 16.91% | 13.27% | 5.56% | 36.90% | 4.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.15% | 35.16% | 0.92% | 17.01% | 8.71% |
| Change in Net Operating Assets | 730.99% | 106.25% | -513.90% | -522.08% | 121.15% |
| Cash from Operations | 15.97% | 38.65% | -176.25% | 1.17% | 35.79% |
| Capital Expenditure | -118.96% | 24.55% | 27.64% | -48.44% | 27.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -499.70% | 20.49% | 806.52% | -76.22% | 35.41% |
| Cash from Investing | -523.57% | 23.33% | 3,219.00% | -93.06% | 53.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,983.84% | 189.09% | -41.23% | -60.05% | 6,216.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,983.84% | 189.09% | -41.23% | -60.05% | 6,216.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.84% | 1,130.07% | 80.17% | -302.61% | 146.21% |